Amphastar Pharmaceuticals, Inc. (AMPH) vs Bicara Therapeutics Inc. Common Stock (BCAX)

A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and Bicara Therapeutics Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Amphastar Pharmaceuticals, Inc. logo
AMPH
Amphastar Pharmaceuticals, Inc.
$1.11B
$25.13HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Bicara Therapeutics Inc. Common Stock logo
BCAX
Bicara Therapeutics Inc. Common Stock
$1.09B
$16.63HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT

Total return — AMPH vs BCAX

growth of $100 · dividends reinvested · last 2y
AMPH -47.2% (-27.4%/yr)BCAX -26.1% (-14.1%/yr)BCAX compounded faster over this window
406080100120Start $10020252026$53$74
AMPH BCAX

AMPH vs BCAX: by the numbers

  • •AMPH is the larger company ($1.11B vs $1.09B market cap).
  • •AMPH is profitable (10.76% net margin) while BCAX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAMPHBCAX
P/E ratio14.87N/A
Forward P/E8.46N/A
PEG ratio0.11N/A
P/S ratio1.52N/A
P/B ratio1.442.33
EV / EBITDA8.76N/A
FCF yield13.80%N/A

Profitability

MetricAMPHBCAX
Gross margin47.68%0.00%
Operating margin15.66%0.00%
Net margin10.76%0.00%
ROE10.23%-39.54%
ROIC5.93%-42.98%

Growth (annualized)

MetricAMPHBCAX
Revenue CAGR (5Y)13.71%N/A
EPS CAGR (5Y)134.23%N/A
FCF CAGR (5Y)23.90%N/A
Total return CAGR (5Y)6.13%N/A

Frequently asked

Is AMPH or BCAX more profitable?
AMPH runs the higher net margin — AMPH at 10.76% versus BCAX at 0.00%.

Go deeper

Full AMPH analysisFull BCAX analysisInteractive comparison tool

Dig into the metrics

Amphastar Pharmaceuticals P/E ratioAmphastar Pharmaceuticals ROEBicara Therapeutics Inc. Common Stock ROEAmphastar Pharmaceuticals operating marginBicara Therapeutics Inc. Common Stock operating marginAmphastar Pharmaceuticals revenue growthBicara Therapeutics Inc. Common Stock revenue growthAmphastar Pharmaceuticals free cash flowBicara Therapeutics Inc. Common Stock free cash flow

Amphastar Pharmaceuticals & Bicara Therapeutics Inc. Common Stock appear in these rankings

Highest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.